Inventor
Ulf Lindahl
Inventor
Uppsala, SE
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C08Bprimary
C08BPolysaccharides21%
C12NMicroorganisms or enzymes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
C12YEnzymes16%
A61KPreparations for medical, dental or toiletry purposes11%
A01KAnimal husbandry5%
C07HSugars5%
Y02ATechnologies for adaptation to climate change5%
PatentTitleYear
9,480,701'Low anticoagulant heparins'20169,475,888'Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use'20168,809,620'Heparanase deficient non-human mammals'20147,399,626'Glucuronyl C5-epimerase, DNA encoding the same and uses thereof'20086,887,698'Glucuronyl C5-epimerase, DNA encoding the same and uses thereof'20056,764,844'DNA sequence encoding a novel glucuronyl C5-epimerase'20044,496,550'Oligosaccharides having selective anticoagulation activity'19854,303,651'Heparin fragments having selective anticoagulation activity'1981Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1981Patents assigned to KABI AB (1)· patent assignee history
1981–2016Based in Uppsala, SE· patent location history
2004–2008Patents assigned to BIOTIE THERAPIES CORP (2)· patent assignee history
2005–2008Patents assigned to INALCO SPA (2)· patent assignee history
2016Patents assigned to DILAFOR AB (1)· patent assignee history
2016Patents assigned to DILAFORETTE AB (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BIOTIE THERAPIES CORP | 2 | 2004–2008 |
| INALCO SPA | 2 | 2005–2008 |
| DILAFOR AB | 1 | 2016 |
| DILAFORETTE AB | 1 | 2016 |
| KABI AB | 1 | 1981 |
Locations
| Location | Patents | Span |
|---|---|---|
| Uppsala, SE | 8 | 1981–2016 |